His scientific interests lie mostly in Internal medicine, Cardiology, Radiology, Surgery and Coronary atherosclerosis. His study involves Angiography, Myocardial infarction, Infarction, Revascularization and Coronary arteries, a branch of Internal medicine. His study in Angina, Coronary artery disease, Ejection fraction, Stenosis and Artery is carried out as part of his Cardiology studies.
Within one scientific family, Jacques Lespérance focuses on topics pertaining to Blood pressure under Artery, and may sometimes address concerns connected to Clinical trial, Diameter stenosis and Right coronary artery. His biological study focuses on Intravascular ultrasound. His Coronary atherosclerosis research integrates issues from Atheroma and Cholesterol.
His primary areas of study are Internal medicine, Cardiology, Surgery, Radiology and Artery. Coronary artery disease, Myocardial infarction, Coronary atherosclerosis, Angina and Ejection fraction are the subjects of his Internal medicine studies. His research integrates issues of Restenosis and Angiography in his study of Cardiology.
His work deals with themes such as Coronary angiography, Lumen and Reproducibility, which intersect with Radiology. His Artery research is multidisciplinary, incorporating perspectives in Blood flow and Pulmonary artery. As a member of one scientific family, he mostly works in the field of Coronary arteries, focusing on Right coronary artery and, on occasion, Percutaneous coronary intervention.
His primary scientific interests are in Internal medicine, Cardiology, Radiology, Artery and Surgery. His Internal medicine study is mostly concerned with Myocardial infarction, Coronary atherosclerosis, Acute coronary syndrome, Angina and Coronary arteries. The various areas that Jacques Lespérance examines in his Coronary atherosclerosis study include Atheroma and Cholesterol.
His work on Coronary artery disease, Percutaneous coronary intervention, Intravascular ultrasound and Coronary angiography as part of general Cardiology study is frequently linked to In patient, bridging the gap between disciplines. His studies in Radiology integrate themes in fields like Anomaly and Cardiac catheterization. His research in the fields of Vascular Patency overlaps with other disciplines such as Term.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
Leonard Schwartz;Martial G. Bourassa;Jacques Lespérance;Harold E. Aldridge.
The New England Journal of Medicine (1988)
Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.
J C Tardif;G Cöté;J Lespérance;M Bourassa.
The New England Journal of Medicine (1997)
The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.
Lucien Campeau;Marc Enjalbert;Jacques Lespérance;Martial G. Bourassa.
The New England Journal of Medicine (1984)
Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation.
C M Grondin;L Campeau;J Lesperance;M Enjalbert.
Circulation (1984)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
Jean-Claude Tardif;Jean Grégoire;Philippe L. L’Allier;Reda Ibrahim.
JAMA (2007)
Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery.
Campeau L;Enjalbert M;Lespérance J;Vaislic C.
Circulation (1983)
Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries.
B R Chaitman;J Lespérance;J Saltiel;M G Bourassa.
Circulation (1976)
A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.
D Waters;J Lespérance;M Francetich;D Causey.
Circulation (1990)
Discrepancies Between Cineangiographic and Postmortem Findings in Patients with Coronary Artery Disease and Recent Myocardial Revascularization
Claude M. Grondin;Ihor Dyrda;André Pasternac;Lucien Campeau.
Circulation (1974)
Prognostic significance of progression of coronary atherosclerosis.
D Waters;T E Craven;J Lespérance.
Circulation (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Montreal Heart Institute
Montreal Heart Institute
Golden Jubilee National Hospital
University of Montreal
University of California, San Francisco
University of California, San Diego
University of Washington
Leiden University Medical Center
Cincinnati Children's Hospital Medical Center
Montreal Heart Institute
Carnegie Mellon University
University of Southern California
Lawrence Berkeley National Laboratory
University of Glasgow
Australian National University
University of California, Davis
Cardiff University
University of Maryland, Baltimore
Kagoshima University
University of Copenhagen
University of Auckland
Gifu Pharmaceutical University
University of Edinburgh
University of Padua
University of Perugia
European Organization for Nuclear Research